Drug Profile
PT 11
Latest Information Update: 18 Feb 2008
Price :
$50
*
At a glance
- Originator Palatin Technologies
- Class Diagnostic agents; Heavy metals; Imaging agents; Technetium compounds
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 05 Oct 2001 No-Development-Reported for Diagnostic imaging in Japan (Unknown route)
- 03 Dec 1998 Preclinical development for Diagnostic imaging in Japan (Unknown route)